Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 5/20 | 0.61 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.39 |
| ▸ | EPAS1 | Q99814 | 4/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.35 |
| ▸ | STAT3 | P40763 | 1/20 | 0.35 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25252922 | 0.81 | ALOX15 (0.59) | ALOX15HIF1AEPAS1TSHRKMT2A | |
| SCHEMBL9575207 | 0.80 | ALOX15 (0.57) | ALOX15HIF1AEPAS1TSHRKMT2A | |
| SCHEMBL30366157 | 0.78 | ALOX15 (0.50) | ALOX15TSHRKMT2AMEN1CYP3A4 | |
| SCHEMBL9390107 | 0.78 | MAPT (0.38) | ALOX15TSHRKMT2AMEN1CYP3A4 | |
| SCHEMBL214881 | 0.77 | ALOX15 (0.54) | ALOX15HIF1AEPAS1TSHRKMT2A | |
| SCHEMBL18643950 | 0.77 | ALOX15 (0.54) | ALOX15HIF1AEPAS1TSHRKMT2A | |
| SCHEMBL5907126 | 0.77 | ALOX15 (0.54) | ALOX15HIF1AEPAS1TSHRKMT2A | |
| SCHEMBL17106157 | 0.76 | ALOX15 (0.48) | ALOX15HIF1AEPAS1TSHRCYP3A4 | |
| SCHEMBL17106152 | 0.76 | ALOX15 (0.48) | ALOX15HIF1AEPAS1TSHRCYP3A4 | |
| SCHEMBL17106247 | 0.76 | ALOX15 (0.48) | ALOX15HIF1AEPAS1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12194020-B2 | Reversing baldness through cannabinoid receptor activation | POSTREL RICHARD (US) | 2025-01-14 | — | — | US | claimed |
| US-20220249434-A1 | Reversal of Baldness in Men and Women through Cannabinoid Receptor Activation | POSTREL RICHARD (US) | 2022-08-11 | — | — | US | claimed |
| US-11331300-B2 | Reversing baldness through follicle regeneration | POSTREL RICHARD (US) | 2022-05-17 | — | — | US | claimed |
| US-20200078333-A1 | Healthier Aging in Domesticated Animals | POSTREL RICHARD (US) | 2020-03-12 | — | — | US | claimed |
| US-20190030044-A1 | HUMAN LIFE EXTENSION THERAPY THROUGH MOLECULAR, CELLULAR AND SUBCELLULAR MANAGEMENT OF BIOCHEMICAL REQUIREMENTS OF MITOCHONDRIA AND OF OTHER ORGANELLE PROCESSES ASSOCIATED WITH THE ADVENT OF DISEASE AND/OR AGING | POSTREL RICHARD (US) | 2019-01-31 | — | — | US | claimed |
| US-20190029993-A1 | QUALITY OF LIFE EXTENSION THERAPIES RELATING TO AGING, FOOD ALLERGIES, PAIN AND REDUCED VIGOR BY MANAGING MOLECULAR, CELLULAR AND SUBCELLULAR BIOCHEMICAL REQUIREMENTS OF MITOCHONDRIA AND OTHER ORGANELLE PROCESSES | REVIGORON LLC | 2019-01-31 | — | — | US | claimed |
| WO-2018118197-A1 | HEALTHIER AGING IN DOMESTICATED ANIMALS | POSTREL RICHARD (US) | 2018-06-28 | — | — | WO | claimed |
| JP-57011978-A | — | — | None | — | — | JP | disclosed |
| US-20250205175-A1 | Anti-Aging Composition with mTOR inhibitor for Humans and Other Mammals | POSTREL RICHARD (US) | 2025-06-26 | — | — | US | disclosed |
| US-20250152562-A1 | Compositions to Enhance and Extend Quality of Life | POSTREL RICHARD (US) | 2025-05-15 | — | — | US | disclosed |
| US-12280019-B2 | Anti-aging therapy for humans and other mammals | POSTREL RICHARD (US) | 2025-04-22 | — | — | US | disclosed |
| US-12220407-B2 | Life extension for humans and other mammals | POSTREL RICHARD (US) | 2025-02-11 | — | — | US | disclosed |
| US-12201589-B2 | Anti-aging therapy for canines and other domesticated animals | POSTREL RICHARD (US) | 2025-01-21 | — | — | US | disclosed |
| US-20190054135-A1 | PLANT OR MICROORGANISM-DERIVED CAROTENOID-OXYGEN COPOLYMER COMPOSITIONS, METHODS OF IDENTIFYING, QUANTIFYING AND PRODUCING SAME AND USES THEREOF | AVIVAGEN INC. (CA) | 2019-02-21 | — | — | US | disclosed |
| US-20190030044-A1 | HUMAN LIFE EXTENSION THERAPY THROUGH MOLECULAR, CELLULAR AND SUBCELLULAR MANAGEMENT OF BIOCHEMICAL REQUIREMENTS OF MITOCHONDRIA AND OF OTHER ORGANELLE PROCESSES ASSOCIATED WITH THE ADVENT OF DISEASE AND/OR AGING | POSTREL RICHARD (US) | 2019-01-31 | — | — | US | disclosed |
| US-20190029993-A1 | QUALITY OF LIFE EXTENSION THERAPIES RELATING TO AGING, FOOD ALLERGIES, PAIN AND REDUCED VIGOR BY MANAGING MOLECULAR, CELLULAR AND SUBCELLULAR BIOCHEMICAL REQUIREMENTS OF MITOCHONDRIA AND OTHER ORGANELLE PROCESSES | REVIGORON LLC | 2019-01-31 | — | — | US | disclosed |
| EP-3420004-A1 | PLANT OR MICROORGANISM-DERIVED CAROTENOID-OXYGEN COPOLYMER COMPOSITIONS, METHODS OF IDENTIFYING, QUANTIFYING AND PRODUCING SAME AND USES THEREOF | Avivagen Inc. (CA) | 2019-01-02 | — | — | EP | disclosed |
| WO-2018118197-A1 | HEALTHIER AGING IN DOMESTICATED ANIMALS | POSTREL RICHARD (US) | 2018-06-28 | — | — | WO | disclosed |
| WO-2017143460-A1 | PLANT OR MICROORGANISM-DERIVED CAROTENOID-OXYGEN COPOLYMER COMPOSITIONS, METHODS OF IDENTIFYING, QUANTIFYING AND PRODUCING SAME AND USES THEREOF | AVIVAGEN INC. (CA) | 2017-08-31 | — | — | WO | disclosed |
| JP-S5711978-A | 2,6,6-TRIMETHYL-2-(2-PROPYNYL OR ALLYL)-TETRAHYDROPYRAN, ITS PREPARATION AND UTILIZATION | T HASEGAWA CO LTD | 1982-01-21 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190054135-A1 | PLANT OR MICROORGANISM-DERIVED CAROTENOID-OXYGEN COPOLYMER COMPOSITIONS, METHODS OF IDENTIFYING, QUANTIFYING AND PRODUCING SAME AND USES THEREOF | PPOX, LPO, CBR3 | ALOX15 37/4885HIF1A 628/4885EPAS1 1666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.